[WEBINAR] Medical Devices & Diagnostics: Current view of the entire ecosystem

Join our June 3 webinar to hear insights from four fresh Ipsos studies that offer a data-based perspective across the challenges and opportunities for medical devices & diagnostics manufacturers, as well key strategic considerations to best navigate this new environment. Topics for the session include exploring:

  • Evolution of the COVID-19 testing market: Adoption rates, testing scenarios, methodologies and core value drivers
  • Hospital operations & purchase decision-making: Impact on testing/procedure demand, adapted clinical strategies and the return to elective procedures, as well as the path forward for capital equipment purchases/budgets, in both the laboratory and operating room
  • Sales & e-detailing: Stakeholder receptivity to virtual communication channels and recommendations for successful e-detailing interactions
  • Access considerations: While there has been minimal impact on policy decision-making process, benefit generosity is threatened by membership declines and provider pressure to increase reimbursement rates

Ipsos just completed four surveillance studies to inform these learnings and we look forward to bringing you the fresh insights:

  1. Lab surveillance with 75 US clinical lab directors/managers
  2. Surgeon surveillance with 530 US surgeons across a variety of specialties
  3. Payer surveillance with 12 US medical/pharmacy directors at major insurers
  4. Hospital administrator surveillance with 15 non-clinical stakeholders at hospitals and health systems

If you can’t attend live, please register to receive the recording.

Register today! →

Speakers :

  • Janna Pattison, VP, Medical Devices & Diagnostics, Ipsos

  • Meghan Gavaghan, VP, US, Market Access

  • Dan Carlow, Director, Market Access, Ipsos

Consumer & Shopper